Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PITYRIASIS RUBRA PILARIS”

6 trials

Showing 6 of 6 results

Testing effectiveness (Phase 2)Study completedNCT03975153
What this trial is testing

Guselkumab in the Treatment of Pityriasis Rubra Pilaris (PRP)

Who this might be right for
Pityriasis Rubra Pilaris
Oregon Health and Science University 15
Testing effectiveness (Phase 2)Study completedNCT03485976
What this trial is testing

Ixekizumab in the Treatment of Pityriasis Rubra Pilaris (PRP)

Who this might be right for
Pityriasis Rubra Pilaris
Oregon Health and Science University 12
Testing effectiveness (Phase 2)Looking for participantsNCT06444399
What this trial is testing

Deucravacitinib (BMS-986165) for Pityriasis Rubra Pilaris

Who this might be right for
Pityriasis Rubra Pilaris
Mayo Clinic 12
Post-approval studies (Phase 4)Ended earlyNCT00815633
What this trial is testing

A Pilot Study of Alefacept for the Treatment of Pityriasis Rubra Pilaris

Who this might be right for
Pityriasis Rubra Pilaris
Joshua Zeichner 1
Early research (Phase 1)Study completedNCT03342573
What this trial is testing

Cosentyx (Secukinumab) for the Treatment of Adult Onset Pityriasis Rubra Pilaris

Who this might be right for
PITYRIASIS RUBRA PILARIS
Mayo Clinic 12
Post-approval studies (Phase 4)Not Yet RecruitingNCT07497620
What this trial is testing

Bimzelx (Bimekizumab) For The Treatment Of Adult Onset PRP

Who this might be right for
Pityriasis Rubra Pilaris
Mayo Clinic 12

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation